Skip to main content
Clinical Trials/CTRI/2024/04/065626
CTRI/2024/04/065626Not yet recruitingPhase 3

Comparative study of intravenous bolus doses of nalbuphine with fentanyl in attenuating hemodynamic response to laryngoscopy in patients undergoing nasal intubation for oral and maxillofacial surgery (OMFS) under general anesthesia - Nil

il0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Undergoing nasal intubation in oral and maxillofacial surgery.
  • Patient belonging to American society of Anaesthesiologist physical 1 and 2.

Exclusion Criteria

  • Age >60 or <18
  • Preoperative hypertension, coronary artery disease (CAD), cardiac conduction defects, congenial heart disease, hemodynamic instability and associated comorbidity.
  • Obesity ( body mass index >30 kg per square meter).
  • Mouth opening less than or equal to 2.5 fingers or inability to do laryngoscopy.
  • MPG grade 4.
  • Patients with nasal fracture.

Investigators

Sponsor
il

Similar Trials